Michael D West - Net Worth and Insider Trading

Michael D West Net Worth

The estimated net worth of Michael D West is at least $1 Million dollars as of 2024-05-05. Michael D West is the Co-CEO of Lineage Cell Therapeutics Inc and owns about 882,864 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $935,836. Michael D West is also the CEO of AgeX Therapeutics Inc and owns about 15,460 shares of AgeX Therapeutics Inc (AGE) stock worth over $171,606. Details can be seen in Michael D West's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael D West has not made any transactions after 2018-12-10 and currently still holds the listed stock(s).

Transaction Summary of Michael D West

To

Michael D West Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael D West owns 5 companies in total, including AgeX Therapeutics Inc (AGE) , Lineage Cell Therapeutics Inc (LCTX) , and OncoCyte Corp (OCX) among others .

Click here to see the complete history of Michael D West’s form 4 insider trades.

Insider Ownership Summary of Michael D West

Ticker Comapny Transaction Date Type of Owner
AGE AgeX Therapeutics Inc 2018-12-10 director & Chief Executive Officer
LCTX Lineage Cell Therapeutics Inc 2017-08-22 director
OCX OncoCyte Corp 2015-12-30 director
2015-02-13 director & VP of Technology Integration
2007-10-09 director

Michael D West Latest Holdings Summary

Michael D West currently owns a total of 2 stocks. Among these stocks, Michael D West owns 882,864 shares of Lineage Cell Therapeutics Inc (LCTX) as of August 22, 2017, with a value of $935,836 and a weighting of 84.5%. Michael D West also owns 15,460 shares of AgeX Therapeutics Inc (AGE) as of December 10, 2018, with a value of $171,606 and a weighting of 15.5%.

Latest Holdings of Michael D West

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LCTX Lineage Cell Therapeutics Inc 2017-08-22 882,864 1.06 935,836
AGE AgeX Therapeutics Inc 2018-12-10 15,460 11.10 171,606

Holding Weightings of Michael D West


Michael D West Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael D West has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 2,000 shares on August 22, 2017, which cost Michael D West around $5,200.

According to the SEC Form 4 filings, Michael D West has made a total of 0 transactions in AgeX Therapeutics Inc (AGE) over the past 5 years. The most-recent trade in AgeX Therapeutics Inc is the acquisition of 4,000 shares on December 10, 2018, which cost Michael D West around $15,440.

Insider Trading History of Michael D West

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael D West Trading Performance

GuruFocus tracks the stock performance after each of Michael D West's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael D West is 1.87%. GuruFocus also compares Michael D West's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael D West within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael D West's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael D West

Average Return

Average return per transaction

Outperforming Transactions

2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 15.74
Relative Return to S&P 500(%) 13.5

Michael D West Ownership Network

Ownership Network List of Michael D West

No Data

Ownership Network Relation of Michael D West


Michael D West Owned Company Details

What does AgeX Therapeutics Inc do?

Who are the key executives at AgeX Therapeutics Inc?

Michael D West is the director & Chief Executive Officer of AgeX Therapeutics Inc. Other key executives at AgeX Therapeutics Inc include director & 10 percent owner Juvenescence Us Corp. , Chief Financial Officer Park Andrea Eun Jae , and Chief Financial Officer Russell Skibsted .

AgeX Therapeutics Inc (AGE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AgeX Therapeutics Inc (AGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AgeX Therapeutics Inc (AGE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AgeX Therapeutics Inc (AGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AgeX Therapeutics Inc Insider Transactions

No Available Data

Michael D West Mailing Address

Above is the net worth, insider trading, and ownership report for Michael D West. You might contact Michael D West via mailing address: Agex Therapeutics, Inc., 1101 Marina Village Parkway, Suite 201, Alameda Ca 94501.

Discussions on Michael D West

No discussions yet.